-
Happy performance!
Time of Update: 2022-02-16
Kanghong Pharmaceutical's 2021 annual report performance forecast shows that it is expected to achieve a net profit of 400 million to 520 million yuan in 2021, an increase of 248% to 293%, and a basic earnings per share of 0.
-
Industry: 2022 will be a key year for the performance and logic of the traditional Chinese medicine sector
Time of Update: 2022-02-16
Judging from the 2021 performance forecast released by A-share pharmaceutical and biological listed companies, the traditional Chinese medicine sector has a beautiful 2021 annual report performance forecast with the help of policies .
"Policy + pharmaceutical consumption upgrade + performance improvement + valuation advantage" jointly builds investment opportunities in the traditional Chinese medicine industry.
-
The seventh batch of centralized procurement of drugs has been launched. What are the highlights worth paying attention to?
Time of Update: 2022-02-16
com, in 2020, the sales of omeprazole sodium for injection in the terminals of public medical institutions nationwide will be 5 billion yuan.
com data, in 2020, the market size of cefixime in public medical institutions in China will exceed 3 billion yuan, of which capsules account for about 26% .
-
How should Chinese medicine companies respond to the rising price of Chinese herbal medicines?
Time of Update: 2022-02-16
In this regard, the industry believes that for related enterprises, it is necessary to strengthen the connection and technical guidance with Chinese herbal medicine growers from the aspect of planting, to ensure the orderly development of the supply-side herbs, and to continuously improve the quality of Chinese herbal medicines, in order to better.
-
In 2022, a large wave of drug prices will be reduced!
Time of Update: 2022-02-16
According to news on January 10 at the national level, China will normalize and institutionalize the centralized procurement of drugs and high-value medical consumables.
-
Inventory of China's CDE drug application in 2021
Time of Update: 2022-02-16
Figure 7 Number of registration applications for various types of biological products (unit: piece) (The above data source: Yaodu-China Approval/Registration Database) Review and approval of drug registration applications In order to promote the research and development of high-quality drugs, China's "Measures for the Administration of Drug Registration" has established four accelerated drug listing procedures: special approval, breakthrough therapy drugs, conditional approval, and priority review and approval .
-
The first in the country!
Time of Update: 2022-02-16
2-type improved new drug tadalafil oral dissolving film entered the stage of administrative approval and is expected to be approved for marketing in the near future, becoming the first in China .
-
Hengrui, Chia Tai Tianqing, and Fosun Pharma lead the IND application of Category 1 new drugs!
Time of Update: 2022-02-16
Looking back at the IND applications for Category 1 new drugs in recent years, it can be found that the number of applications has grown rapidly since 2015.
After almost every major reform measure, the number of new Class 1 drugs applied for clinical applications will increase substantially once .
-
The blockbuster centralized procurement alliance has landed, and the bid will be opened one month later!
Time of Update: 2022-02-16
According to the document, the centralized procurement of drugs by the Yangtze River Delta Alliance involves 47 drugs including atorvastatin, entecavir, paroxetine, imatinib, and dapoxetine, all of which are domestically sourced .
-
2022 Shanghai International Chromatography Application Technology and Instrument Exhibition
Time of Update: 2022-02-16
With many years of rich exhibition experience, the organizer will carry out strong organizational publicity work, attracting new products and technologies from chromatography, manufacturers, distributors, user communication platforms, industry merchants, agents, product (buyers, sellers) business opportunities exchange platforms, etc.
-
2022 Shanghai International Industrial Enzyme and Biocatalysis Exhibition
Time of Update: 2022-02-16
This conference will discuss and exchange topics such as enzyme discovery and enzyme engineering, new applied industrial enzymes, biocatalysis R&D and application, and invite industry elites to present a grand event in the field of industrial biotechnology to strengthen international exchanges and promote industrial The development of biotechnology industry enhances the ability of industrial biotechnology integration and innovation and achievement transformation, and promotes exchanges and cooperation between Chinese enterprises and institutions and world-renowned enterprises and research institutions .
-
2022 Guangzhou International Industrial Assembly and Transmission Technology Exhibition
Time of Update: 2022-02-16
3. Industrial automation: complete sets of technology for automatic production lines, motion and control systems, controllers , servo motors, servo drives, frequency converters, reducers, motors, process instruments and analytical instruments, industrial networks, field buses, pneumatic components, transmission equipment, safety equipment/screens and other non-standard automation equipment, 3D printing, connector wires and Cable accessories, etc.
-
The seventh batch of national mining official announcement!
Time of Update: 2022-02-16
In 2020, the total sales volume of public medical institutions in China will exceed 60 billion yuan, and a total of 26 injections will be included in the seventh batch of national procurement .
-
2022 Shanghai International Distillation, Rectification Technology and Equipment Exhibition
Time of Update: 2022-02-16
2022 Shanghai distillation, distillation technology and Equipment Exhibition ◆ 》》 Basic information: Time: August 11-13, 2022 Venue: Shanghai New International Expo Center Time: August 11-13. 2022 Ven
-
The "Good Manufacturing Practice for Cosmetics" will come into force on July 1, 2022
Time of Update: 2022-02-16
★ Policies and regulations On January 6, 2022, China National Institute for Food and Drug Control issued the "Key Points for the Acceptance and Review of Application for Registration Renewal of Special Cosmetics (Trial)" (hereinafter referred to as "Key Points") and related documents, which will be implemented from the date of issuance .
-
The performance of 7 pharmaceutical machine companies is expected to be positive. Can the industry continue to boom in 2022?
Time of Update: 2022-02-16
For example, Chutian Technology stated that during the reporting period, the company focused on the development of biopharmaceutical equipment, has basically completed the layout of biopharmaceutical front-end equipment, and made great achievements in the high-end market and import substitution .
-
The number of domestic PD-(L)1 has reached 12, and it may become a trend to reduce the price to enter the "ordinary people's home"
Time of Update: 2022-02-16
In 2021, the K medicine patient assistance project released a new plan: From January 1, 2021, patients only need to pay for 4 courses of treatment and cost 140,000 yuan.
-
2022 Guangzhou International Chain Drive and Equipment Exhibition
Time of Update: 2022-02-16
With many years of rich exhibition experience, the organizer will carry out strong organizational publicity work, attracting new products and technologies from chain drive, manufacturers, distributors, user communication platforms, industry merchants, agents, products (buyers, sellers) business opportunities exchange platform Etc.
-
Green Valley Pharmaceutical's "Ninth Phase One" clinical application for new indications was undertaken by CDE
Time of Update: 2022-01-27
In 2020, GV-971 applied to be included in the medical insurance catalog, but failed to pass the assessment of the comprehensive group.
This time successfully entered the new list of medical insurance .
-
The traditional Chinese medicine sector hits the limit again, is the market sustainable?
Time of Update: 2022-01-27
In recent years, policies to support the development and innovation of traditional Chinese medicine have continued to help the development and growth of the traditional Chinese medicine industry .
